Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maggie L Bobbin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Annual Review of Pharmacology and Toxicology|January 8, 2016
RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?Maggie L Bobbin, John J Rossi
Genome Medicine|May 29, 2015
RNA interference approaches for treatment of HIV-1 infectionMaggie L Bobbin, John C Burnett, John J Rossi
Frontiers in Genetics|November 7, 2012
Current progress of RNA aptamer-based therapeuticsJiehua Zhou, Maggie L Bobbin, John C Burnett, et al.
Nature|September 14, 2018
In vivo CRISPR editing with no detectable genome-wide off-target mutationsPinar Akcakaya, Maggie L Bobbin, Jimmy A Guo, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Annual Review of Pharmacology and Toxicology|January 8, 2016
RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?Maggie L Bobbin, John J Rossi
Genome Medicine|May 29, 2015
RNA interference approaches for treatment of HIV-1 infectionMaggie L Bobbin, John C Burnett, John J Rossi
Frontiers in Genetics|November 7, 2012
Current progress of RNA aptamer-based therapeuticsJiehua Zhou, Maggie L Bobbin, John C Burnett, et al.
Nature|September 14, 2018
In vivo CRISPR editing with no detectable genome-wide off-target mutationsPinar Akcakaya, Maggie L Bobbin, Jimmy A Guo, et al.
Pageof 1